In Memory of Julie Greene
With deep regret, Mad in America announces another loss in our contributor community. Julie C. Greene, writer and antipsychiatry advocate, lost her battle with kidney disease on November 29 at her home in Beaver Falls, Pennsylvania. Julie had been an MIA blogger since 2014, including several pieces on the dangers of lithium.
People Diagnosed with Bipolar Disorder at Increased Risk for Parkinson’s
Increased Parkinson's risk could be related to lithium, antipsychotic, and antiepileptic drug use.
Lithium: A Survivor’s Guide for Parents
When I was a young adult, I was misdiagnosed with bipolar disorder and placed on lithium. I am 61 years old now, living on the edge of end-stage kidney disease. If I could undo everything, by all means, I would not have taken this drug. It is not safe for anyone at any age.
Prenatal Valproate Exposure Linked with ADHD Diagnosis in Children
Children who were exposed to anti-seizure drug valproate in utero were 48% more likely to develop ADHD, according to a new study.
The Good, the Bad, and the Ugly: An Infographic on Bipolar Drugs
Bipolar drug therapy is a balancing act of benefits vs. harms. Odds of attributable benefit cluster in a 15-25% band, so 75%-85% don’t see substantial benefit. Stated differently, if five people take a bipolar drug, only one is likely to see substantial improvement due to it, but all five will have side effects.
Valproate Linked to Decreased Brain Volume in Children Diagnosed with Bipolar Disorder
Researchers find that valproate decreases brain volume in a region associated with emotion processing across all participants.
The $3 Billion Research Breakdown
In this piece for Medscape, Jodi S. Cohen chronicles the research malpractice case of child psychiatrist Mani Pavuluri, who put vulnerable children at serious risk...
Primary Care Practitioners May Mistake Irritability as Bipolar Disorder in Youth
Family medicine and pediatric providers are less confident in their assessment of irritability in youth than psychiatric providers, which may lead to overdiagnosis of bipolar disorder.
Study Explores Meanings of Bipolar Disorder to Those Diagnosed
The narratives about Bipolar Disorder promoted by drug companies may influence how those diagnosed understand themselves.
Anticholinergic Medications Linked to Dementia Similar to Early Alzheimer’s
A new study, published in the Journal of Clinical Psychiatry, investigates the effects of anticholinergic medications, such as antidepressants and antipsychotics, on cognition in older adults diagnosed with schizophrenia.
Freud in the Scanner: A Revival of Interest in Introspection
From Aeon: For the past several decades, mainstream mental health professionals as well as the general public have dismissed Freud's ideas, turning instead to neuroscience...
Children Diagnosed with ADHD Younger are More Likely to get Multiple Medications
New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.
The Issue of Over-Diagnosing in Psychiatry
From The Concordian: On October 30th, Dr. Joel Paris, a professor of psychiatry at McGill University, gave a lecture about the dangers and consequences of...
New Research Documents Widening Mortality Gap for Bipolar and Schizophrenia
Analysis of longitudinal data from 2000-2014 demonstrate mortality gap is widening between persons with a diagnosis of bipolar or schizophrenia compared to the general population
In this piece for Healing Journey, Anne O'Beirne briefly summarizes the history of the medical usage of lithium and describes the impact that the drug has...
What If We Are All Wrong About Mental Illness?
From Thoughtful Living: The biomedical model of psychiatry, along with the DSM, is deeply flawed and can often be misleading. To improve, mental health services...
Childhood Bipolar Disorder More Rare Than Previously Claimed, Study Finds
Re-examination of meta-analytic claims finds the prevalence of pediatric bipolar disorder is close to zero.
Missouri Sued for Over-Drugging Foster Children
From Reuters: Two youth legal advocacy groups have filed a lawsuit against Missouri for over-exposing foster children to psychotropic drugs. The lawsuit seeks a court...
Psychiatric Medications Heighten Risk for Major Bone Fractures
Important assessment tool found to underestimate the risk for fracture in patients on psychiatric medication.
Anticonvulsant Implicated in Birth Defects in up to 4,100 Children, French Study Finds
Between 2,150 and 4,100 children suffered from severe malformations connected to valproate prescription.
Might Antidepressants Create Treatment Resistance?
From Psychiatric Times: A recent study of individuals diagnosed with bipolar II disorder found that patients who have taken antidepressants in the past are less likely to respond...
Psychiatric Drug Ads Lead to More Prescriptions and Worse Treatment
A new analysis published in the The Journal of Clinical Psychiatry investigates the public health effects of direct-to-consumer advertisements for psychiatric drugs. The researchers...
Consequences of Taking the Yellow Brick Road: Lithium Carbonate 1984-1996
I was first given Lithium Carbonate in the spring of 1984, and I was taken off Lithium by my attending physician in 1996, but left on other drugs. It took me until 2012 to realize psychiatry is a sham. So often people tell me, “I don’t care what my life is like ten years from now. I only want to feel good now.” I may have said the same thing twenty years ago. Now I have the hindsight to know that my viewpoint back then was juvenile at best. I try to warn other patients these days. It’s hard to joke around about something that kills people.
My Response to the FDA’s ECT Rule Change
I lived through forced ECT from 2005-2006 at the Institute of Living in Hartford, Connecticut. My experience with ECT was the impetus for me to become involved in the antipsychiatry and Mad Pride movements, although I am not entirely opposed to voluntary mental health treatment. The following is the comment I submitted to the FDA on its proposal to down-classify the ECT shock device.
Update: Massachusetts Benzodiazepine Bill Hearing
The hearing for Bill H4062: Informed Consent for Benzodiazepines and Non-benzodiazepine Hypnotics took place on Monday – in the middle of an April snowstorm! The discussion clarified some important points in the legislation and gave survivors an opportunity to tell their stories. I was so proud to be there and witness the courage, camaraderie, resilience, advocacy, and vulnerability of fellow survivors. This legislation is our chance to be heard. As one survivor said, through tears, to the committee, “Do not let my suffering be in vain. I beg you to pass this bill.”